Global Variation in Opioid Use in Prostate Cancer Trials

This study analyzes the pattern of opioid use among patients with metastatic prostate cancer enrolled in clinical trials conducted in 46 countries.

Read the full article here

Related Articles

CONSORT 2025 Statement

This Special Communication introduces the updated Consolidated Standards of Reporting Trials (CONSORT) 2025 statement, which includes substantive and structural changes to account for recent methodological…